why choose us

First received: June 06, 2023

Clinical Trial: Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: SARS-CoV-2 Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of S-217622 in the Prevention of Symptomatic SARS-CoV-2 Infection in Household Contacts of an Individua

Brief Summary: The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (positive reverse transcription polymerase chain reaction [RT-PCR] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo tablets in participants who are household contacts of an individual with symptomatic COVID-19.

Read more